NICE guidance prioritises SGLT2 inhibitors for those with established or high risk of cardiovascular or kidney disease, with GLP-1 receptor agonists as add-on or alternative therapy where appropriate
The fact that people regained weight after stopping medication wasnt too surprising, but what was striking is just how fast it occurred. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing
However, current and next-gen obesity therapeutics have the potential to vastly improve health outcomes
It was derived from research on melanotan II a peptide initially developed for sunless tanning that unexpectedly induced sexual arousal and erections in early tests
Grossman explained a true adjudication typically involves the agency judging the past conduct of a specific party
28 In rodent models, genetic knockout of the GLP-1R reduces bone quality and maturity of the collagen matrix